Mural Oncology (NASDAQ: MURA) reported Q4 2023 earnings per share (EPS) of -$3.57, up 22.68% year over year. Total Mural Oncology earnings for the quarter were -$59.54 million. In the same quarter last year, Mural Oncology's earnings per share (EPS) was -$2.91.
As of Q2 2024, Mural Oncology's earnings has grown year over year. Mural Oncology's earnings in the past year totalled -$207.45 million.
What was MURA's revenue last quarter?
Mural Oncology (NASDAQ: MURA) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Mural Oncology's revenue was $0.00.
What was MURA's revenue growth in the past year?
As of Q2 2024, Mural Oncology's revenue has grown null year over year. Mural Oncology's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.